Private Equity in Dermatology: Navigating Opportunities and Common Pitfalls for Practice Owners

Private equity deals in healthcare have grown a lot in the last ten years. In 2012, there were only 75 deals, but by 2021, this number had grown to almost 500 deals. Experts think this trend will keep going in 2024. Dermatology is a big part of this growth. The U.S. dermatology market is now worth $7.7 billion, and it is expected to reach $8.6 billion by 2026 with a growth rate of 3.8% per year. This growth is mostly because the population is getting older and more people are paying attention to skin health.

Most dermatology practices in the U.S. are small and split up. About 40% of them are run by a single doctor, and 73% have fewer than five doctors. This situation creates a chance for private equity firms to join up smaller practices into bigger groups. These bigger groups can save money, work more efficiently, and reach more patients.

By 2020, around 15% of dermatology practices in the U.S. were owned by private equity-backed groups. These groups use organizations called Dermatology Management Groups (DMGs) or Management Services Organizations (MSOs) to handle administrative tasks. This lets doctors focus more on caring for patients. From 2012 to 2018, 17 private equity-backed DMGs bought 184 practices, which included about 381 dermatology clinics.

Financial and Operational Benefits of Private Equity Ownership

One big reason dermatology practice owners might sell or work with private equity firms is money. Private equity groups often offer higher prices than other buyers, like internal buyers or non-private equity groups. They also bring lots of money and skilled people. This helps practice owners who may be close to retiring or want to do less management work to get good value for their practice.

After private equity owns a dermatology practice, some improvements usually happen:

• Capital Investment: Private equity firms put money into updating facilities, buying new technology, and adding services. This might include electronic health record (EHR) systems, diagnostic tools, online dermatology platforms, and patient communication tools.
• Administrative Efficiency: These firms make office work smoother and cut costs. Doctors have fewer business worries. Practices get better billing methods, staff schedules, and insurance deals.
• Network Expansion: Being part of a bigger group gives access to more professional contacts. This can help improve reputation and bring more patient referrals.

Private equity firms may offer payment plans with upfront money plus earn-outs or shares in the company. This helps dermatologists match their money goals with the private equity firm’s long-term plans.

Risks and Challenges of Private Equity Involvement

Even though there are good points, private equity investments in dermatology also have challenges. A big worry is that doctors may lose control after selling to private equity. These firms usually want to get profits in 4 to 7 years. They might set rules that don’t fit the practice’s culture or doctor’s ideas. Doctors can feel pressure to make more money, which might affect how they care for patients.

Sometimes cutting costs too much leads to worse care quality, unhappy staff, and more people quitting. For example, one dermatology clinic had problems after private equity took over because financial goals were more important than patient care.

Another problem is debt. Private equity firms often borrow money to buy practices. The practice then owes this money, which can make future investments harder and cause stress if the economy gets worse.

Private equity also tends to increase the number of patients seen. Studies show dermatologists in private equity groups see 4.7% to 17% more patients than doctors who work independently. More patients can strain clinics and lower patient experience.

Many young dermatologists don’t want to work for private equity-owned practices. About 65% of dermatology residents said they are not sure or do not want to work for these groups because of worries about control, care quality, and pay.

Strategic Considerations for Dermatology Practice Owners

Doctors thinking about working with private equity should consider these points:

• Fit with Private Equity Firm: Understand how the firm manages its groups and what its long-term goals are. Check if the firm cares equally about growth and good patient care. Will doctors still make important patient care decisions?
• Legal and Financial Help: Use experienced lawyers and financial advisors. They can help with purchase agreements, ownership shares, agreements among partners, and employee contracts to protect the practice’s interests.
• Effect on Patients and Reputation: Think about how private equity ownership might change how patients feel and the practice’s trust in the community. It is important to communicate openly with staff and patients during the change.
• Private Equity Exit Plans: Know when the firm plans to leave the practice and how this might affect stability and staff. A focus on short-term profit can hurt long-term growth.
• Other Options: Some doctors may want to look at keeping the practice inside the group, merging with other doctors, or partnering with buyers who are not private equity firms and share their values.

By thinking about these, practice owners can make better decisions about private equity participation.

Technology, AI, and Workflow Automation in Private Equity-Backed Dermatology Practices

Private equity-backed dermatology groups want to work more efficiently and give better patient service. Technology like artificial intelligence (AI) and automation can help with these goals.

AI Phone Automation and Patient Help

AI tools like Simbo AI can answer many phone calls automatically. This cuts the work for reception and shortens wait times. Patients can book appointments, get visit instructions, or find answers any time, day or night.

Helping Clinical Work

AI can look at skin images and find signs of possible problems. It helps doctors decide which patients need attention first. This improves diagnosis and personal treatment plans. Private equity firms often invest in these tools to improve the practice’s quality and competitiveness.

Workflow Automation

Software can reduce paperwork by automating tasks like billing, lab orders, and reminders. It connects with EHR systems to avoid repeating work and reduce mistakes. This speeds up billing and improves money management, which fits private equity’s goal of running things efficiently.

Support for Teledermatology

Digital health lets patients in remote places get skin care through teledermatology. These systems connect with AI triage and automatic scheduling, letting practices reach more patients while keeping care standards.

By using AI and automation, private equity-backed dermatology practices can improve their services, lower costs, and make patients happier. Technology is now an important part of private equity investment plans.

Dermatology Workforce and Demographic Trends Affecting Practice Management

Some wider trends also affect how dermatology practices work and how private equity firms decide to invest:

• More Women in Medicine: Now, 85.5% of active dermatologists are women as of 2022. This changes workplace culture, leadership, and patient care styles.
• Physician Shortage: Out of about 1.1 million doctors in the U.S., only 11,000 are dermatologists. This shortage makes demand higher and encourages private equity firms to combine services for efficiency.
• Growing Cosmetic Dermatology: An older population leads to more interest in cosmetic skin treatments, many using natural products. This area is important for business growth and investment.

These trends show practice owners and managers must think about current and future challenges, and how private equity might change their response to these changes.

Final Thoughts on Navigating Private Equity in Dermatology

Private equity in U.S. dermatology is growing. It offers chances and challenges. Practice owners get more money, help running the practice, new technology, and bigger professional networks. But they must also consider risks like losing control, more pressure, culture changes, and the stress of debts from buying the practice.

Practice managers, owners, and IT leaders should carefully check all parts of a deal, plan well, and use technology like AI and automation. These steps can help keep good patient care while adjusting to changes that come with private equity ownership.

By knowing about these issues, dermatology practices can work better with private equity and improve patient care in the long run.